Abstract: Pharmaceutical compositions comprising reboxetine or a pharmaceutically acceptable salt thereof and a muscarinic receptor antagonist (MRA) and methods of treating sleep apnea comprising administering reboxetine or a pharmaceutically acceptable salt thereof and an MRA are described herein. In some embodiments, the MRA is oxybutynin or (R)-oxybutynin or a pharmaceutically acceptable salt thereof.

Abstract: Pharmaceutical compositions comprising Lemborexant or a pharmaceutically acceptable salt thereof and a norepinephrine reuptake inhibitor (NRI) and methods of treating Sleep Apnea comprising administering Lemborexant or a pharmaceutically acceptable salt thereof and an NRI are described herein. In some embodiments, the NRI is atomoxetine or a pharmaceutically acceptable salt thereof. In some embodiments, the pharmaceutical compositions further comprise a muscarinic receptor antagonist (MRA). In some embodiments, the methods of treating Sleep Apnea further comprise administering an MRA. In some embodiments, the MRA is oxybutynin or a pharmaceutically acceptable salt thereof.

Abstract: In general, the invention relates to pharmaceutical compositions comprising a norepinephrine reuptake inhibitor (NRI), muscarinic receptor antagonist, and carbonic anhydrase inhibitor and methods of treating Sleep Apnea comprising the administration of these pharmaceutical compositions.

Abstract: Methods and compositions for the treatment of conditions associated with pharyngeal airway muscle collapse while the subject is in a non-fully conscious state, e.g., sleep apnea and snoring, comprising administration of (i) a norepinephrine reuptake inhibitor (NRI) and (ii) a non myorelaxing hypnotic and/or 5-HT2A inverse agonist or antagonist.

Abstract: Methods and compositions for the treatment of conditions associated with pharyngeal airway muscle collapse while the subject is in a non-fully conscious state, e.g., sleep apnea and snoring, comprising administration of a norepinephrine reuptake inhibitor (NRI) and a muscarinic receptor antagonist.

Abstract: Methods and compositions for the treatment of conditions associated with pharyngeal airway muscle collapse while the subject is in a non-fully conscious state, e.g., sleep apnea and snoring, comprising administration of a norepinephrine reuptake inhibitor (NRI) and a muscarinic receptor antagonist.

Abstract: Methods and compositions for the treatment of conditions associated with pharyngeal airway muscle collapse while the subject is in a non-fully conscious state, e.g., sleep apnea and snoring, comprising administration of a norepinephrine reuptake inhibitor (NRI) and a muscarinic receptor antagonist.

Abstract: An “accordion-like” product display container with a plurality of compartments is provided. The product display container has a collapsed configuration in which the panels are folded up and an expanded display configuration in which the panels form areas for holding product to be displayed. Each compartment in the plurality of compartments further comprises at least one rigidity flap, e.g., a pair of rigidity flaps. The rigidity flaps are deployed into a rigidifying position to stiffen the product display container are resist compression from the expanded display configuration to the collapsed configuration. The display container may be transitioned from the collapsed state to the rigid state solely by deploying the rigidity flaps. The rigidity flaps may be held in place by bottom panels of the compartments.

Abstract: The product display system includes one or more display containers, wherein each display container includes a plurality of panels that are adapted to form an area for holding product to be displayed. Each display container may include one or more container interconnection flaps and one or more apertures adapted to receive the interconnection flaps from another one of the display containers, enabling the plurality of display containers to be coupled together. The system may further include a floor stand adapted to hold the plurality of display containers and/or a tray adapted to receive the plurality of display containers. Each display container in the plurality of display containers may include a mounting mechanism enabling the display container to be hung.

Abstract: An “accordion-like” product display container with a plurality of compartments is provided. The product display container has a collapsed configuration in which the panels are folded up and an expanded display configuration in which the panels form areas for holding product to be displayed. Each compartment in the plurality of compartments further comprises at least one rigidity flap, e.g., a pair of rigidity flaps. The rigidity flaps are deployed into a rigidifying position to stiffen the product display container are resist compression from the expanded display configuration to the collapsed configuration. The display container may be transitioned from the collapsed state to the rigid state solely by deploying the rigidity flaps. The rigidity flaps may be held in place by bottom panels of the compartments.

Abstract: The product display system includes one or more display containers, wherein each display container includes a plurality of panels that are adapted to form an area for holding product to be displayed. Each display container may include one or more container interconnection flaps and one or more apertures adapted to receive the interconnection flaps from another one of the display containers, enabling the plurality of display containers to be coupled together. The system may further include a floor stand adapted to hold the plurality of display containers and/or a tray adapted to receive the plurality of display containers. Each display container in the plurality of display containers may include a mounting mechanism enabling the display container to be hung.